IL314226A - Designed cytokine compositions and methods of use - Google Patents
Designed cytokine compositions and methods of useInfo
- Publication number
- IL314226A IL314226A IL314226A IL31422624A IL314226A IL 314226 A IL314226 A IL 314226A IL 314226 A IL314226 A IL 314226A IL 31422624 A IL31422624 A IL 31422624A IL 314226 A IL314226 A IL 314226A
- Authority
- IL
- Israel
- Prior art keywords
- methods
- cytokine compositions
- designed
- designed cytokine
- compositions
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
- C07K14/54—Interleukins [IL]
- C07K14/55—IL-2
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
- C07K14/54—Interleukins [IL]
- C07K14/5443—IL-15
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/715—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons
- C07K14/7155—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons for interleukins [IL]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/30—Non-immunoglobulin-derived peptide or protein having an immunoglobulin constant or Fc region, or a fragment thereof, attached thereto
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/33—Fusion polypeptide fusions for targeting to specific cell types, e.g. tissue specific targeting, targeting of a bacterial subspecies
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Genetics & Genomics (AREA)
- Gastroenterology & Hepatology (AREA)
- Molecular Biology (AREA)
- Zoology (AREA)
- Toxicology (AREA)
- Immunology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Cell Biology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202263298623P | 2022-01-11 | 2022-01-11 | |
| US202363479178P | 2023-01-09 | 2023-01-09 | |
| US202363479177P | 2023-01-09 | 2023-01-09 | |
| US202363479176P | 2023-01-09 | 2023-01-09 | |
| PCT/US2023/060508 WO2023137346A2 (en) | 2022-01-11 | 2023-01-11 | Designed cytokine compositions and methods of use |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL314226A true IL314226A (en) | 2024-09-01 |
Family
ID=87279672
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL314226A IL314226A (en) | 2022-01-11 | 2023-01-11 | Designed cytokine compositions and methods of use |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20250223330A1 (https=) |
| EP (1) | EP4463469A4 (https=) |
| JP (1) | JP2025502205A (https=) |
| KR (1) | KR20240164594A (https=) |
| CN (1) | CN119053616A (https=) |
| AU (1) | AU2023208031A1 (https=) |
| CA (1) | CA3248134A1 (https=) |
| IL (1) | IL314226A (https=) |
| MX (1) | MX2024008642A (https=) |
| WO (1) | WO2023137346A2 (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL325764A (en) * | 2023-07-13 | 2026-03-01 | Outpace Bio Inc | Designed compositions of interleukin-2 cytokine and methods of use |
| WO2025212606A1 (en) * | 2024-04-01 | 2025-10-09 | Bio-Techne Corporation | Synthetic il-2 polypeptides and conjugates, compositions, and uses thereof |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20210025522A (ko) * | 2018-06-25 | 2021-03-09 | 유니버시티 오브 워싱톤 | 강력하고 선택적인 인터루킨 모방체의 드 노보 디자인 |
| MX2021000801A (es) * | 2018-07-24 | 2021-04-12 | BioNTech SE | Agonistas de il2. |
| CN118510795A (zh) * | 2022-01-07 | 2024-08-16 | 苏州克睿基因生物科技有限公司 | 新型白介素-2多肽 |
-
2023
- 2023-01-11 WO PCT/US2023/060508 patent/WO2023137346A2/en not_active Ceased
- 2023-01-11 MX MX2024008642A patent/MX2024008642A/es unknown
- 2023-01-11 IL IL314226A patent/IL314226A/en unknown
- 2023-01-11 KR KR1020247026696A patent/KR20240164594A/ko active Pending
- 2023-01-11 AU AU2023208031A patent/AU2023208031A1/en active Pending
- 2023-01-11 JP JP2024541803A patent/JP2025502205A/ja active Pending
- 2023-01-11 US US18/727,646 patent/US20250223330A1/en active Pending
- 2023-01-11 CA CA3248134A patent/CA3248134A1/en active Pending
- 2023-01-11 EP EP23740805.9A patent/EP4463469A4/en active Pending
- 2023-01-11 CN CN202380027065.2A patent/CN119053616A/zh active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| US20250223330A1 (en) | 2025-07-10 |
| KR20240164594A (ko) | 2024-11-19 |
| CA3248134A1 (en) | 2023-07-20 |
| MX2024008642A (es) | 2024-09-23 |
| EP4463469A2 (en) | 2024-11-20 |
| AU2023208031A1 (en) | 2024-08-29 |
| EP4463469A4 (en) | 2026-01-14 |
| WO2023137346A2 (en) | 2023-07-20 |
| JP2025502205A (ja) | 2025-01-24 |
| CN119053616A (zh) | 2024-11-29 |
| WO2023137346A3 (en) | 2023-11-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SI4267105T1 (sl) | Sestave protiteles in načini njihove uporabe | |
| IL308041A (en) | Collagen compositions and methods of using them | |
| IL318543A (en) | Protein-targeted compositions for activating fibroblasts and methods for using them | |
| IL314922A (en) | Targeted cytokines and methods of using them | |
| IL314226A (en) | Designed cytokine compositions and methods of use | |
| GB2622995B (en) | CAS13-based compositions and methods of use thereof | |
| IL316049A (en) | Musuntuzumab pharmaceutical preparations and methods of use | |
| IL312928A (en) | Complement Factor B Modulating Preparations and Methods for Using Them | |
| IL315862A (en) | Angiotensinogen modulators and methods of using them | |
| EP4298076A4 (en) | CERAMIC COMPOSITIONS AND METHODS OF USE | |
| IL325628A (en) | Coagulation factor xi modulators and methods of using them | |
| IL317018A (en) | Garden treatment preparations and methods of using them | |
| IL321134A (en) | Olanzapine compounds and methods of use | |
| IL326074A (en) | Fibroblast activation protein-targeting compositions and methods of using them | |
| IL325764A (en) | Designed compositions of interleukin-2 cytokine and methods of use | |
| HK40119758A (en) | Designed cytokine compositions and methods of use | |
| IL326294A (en) | Epilepsy compositions and methods of use | |
| GB202313643D0 (en) | Serping1-sarna compositions and methods of use | |
| GB202310868D0 (en) | compositions and methods of use | |
| IL325884A (en) | Compositions comprising GAL475 and methods of using them | |
| CA3297357A1 (en) | Cytokine compositions and methods of use thereof | |
| IL311518A (en) | Preparations that modulate perkalkerine and methods of using them | |
| GB202511967D0 (en) | Compositions and methods of using same | |
| IL311037A (en) | Lactoferrin preparations and methods of use | |
| IL317319A (en) | Antibody compounds and methods of using them |